The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim results from a phase 2 study of olaparib (without ADT) in men with biochemically-recurrent prostate cancer after prostatectomy, with integrated biomarker analysis.
 
Emmanuel S. Antonarakis
Honoraria - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Clovis Oncology; Dendreon; ESSA; Janssen Biotech; Medivation; Merck; Sanofi
Research Funding - Aragon Pharmaceuticals (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Dendreon (Inst); Exelixis (Inst); Genentech (Inst); Janssen Biotech (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Co-inventor of a biomarker technology that has been licensed to Qiagen
Travel, Accommodations, Expenses - Dendreon; Medivation; Sanofi
 
Hao Wang
No Relationships to Disclose
 
Benjamin A. Teply
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Inovio Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to drug delivery technology with royalties paid via MIT
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen
 
William Kevin Kelly
Honoraria - Constellation Pharmaceuticals; Janssen Oncology
Consulting or Advisory Role - Foundation Medicine; Sanofi
Research Funding - Bayer (Inst); Endocyte (Inst); Exelixis (Inst); Janssen Oncology (Inst); Novartis (Inst); Sanofi (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Janssen Oncology
 
Jamie Willms
No Relationships to Disclose
 
Rana Sullivan
No Relationships to Disclose
 
Serina King
No Relationships to Disclose
 
Catherine Handy Marshall
No Relationships to Disclose
 
Tamara L. Lotan
Consulting or Advisory Role - Janssen Oncology
Research Funding - Ventana Medical Systems